Monetary Management Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Monetary Management Group's BIIB Position: Q2 2021 in Review
Monetary Management Group sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,475 shares — an estimated $413K sold.
Monetary Management Group first reported a position in BIIB in Q4 2013 and held it in 23 quarters. The position peaked at $1.21M in Q2 2019. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.
- Monetary Management Group reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
- Monetary Management Group sold 1,475 Biogen shares in Q2 2021, an estimated $413K.
- Monetary Management Group first reported a position in Biogen in Q4 2013 and held it in 23 quarters.
- Monetary Management Group's Biogen position peaked at $1.21M in Q2 2019.
- 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.
Based on Monetary Management Group's 13F filing for Q2 2021, filed 12 Aug 2021.